Medline Inc. - 8-K Filing

Medline Inc. reports Q3 2026 net sales of $7.9 billion (up 10.4% YoY) and raises full-year organic sales guidance to 10.0%-10.5%. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $MDLN

Read the full article at SEC EDGAR

Part of the story MICROSOFT CORP - 8-K Filing (21 articles)

More Regulatory news